Public Health - Drug Manufacturer-Funded Disease Awareness Campaigns - Registration and Required Disclosure
Hearing (House)
Email me when HB 1133 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 1133. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill forces drug manufacturers and any patient advocacy organization that receives their funding to file a registration with the Maryland Department of Health before launching a disease‑awareness effort. Campaign materials must clearly state the specific drug or device being marketed for the condition featured. This aims to increase transparency for the public about commercial influences behind health information.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 1133
3 free questions a day, no accountHearings
- Health — Bill HearingHealth · Mar 12, 2026
History
- Hearing 3/12 at 1:00 p.m.
- First Reading Health
Sponsors
- Taveras · sponsor
- Acevero
- Hill
- Kaufman
- Lehman
- Odom
- Ruff
- Terrasa
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 1133 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1133 freeOr ask your AI assistant about HB 1133 directly:
Add to Claude, ChatGPT or Cursor